MedTrace Logo

Improving Vitamin D Status In Cystic Fibrosis

NCT00450073 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-02-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to establish an effective method to correct vitamin D deficiency in subjects with cystic fibrosis. The investigators will examine cholecalciferol, ergocalciferol and UV light.

Conditions

Interventions

DRUG

ergocalciferol (vitamin D2)

50,000 IU weekly

DEVICE

Sperti Del Sol Lamp

5 times a week for 12 weeks

DRUG

Vitamin D3

50,000 IU weekly

Sponsors & Collaborators

  • Emory University

    collaborator OTHER

  • Atlanta VA Medical Center

    lead FED

Principal Investigators

  • Vin Tangpricha, M.D. Ph.D. · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00450073 on ClinicalTrials.gov